Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Tumor intrinsic mechanisms leading to cevostamab resistance in multiple myeloma

Blood (2025) 146 (Supplement 1): 2178.

https://doi.org/10.1182/blood-2025-2178

Published: 2025

Journal Articles

Incidence and characteristics of infections in patients with multiple myeloma treated with BCMA bispecific antibodies in British Columbia

Blood (2025) 146 (Supplement 1): 5806.

https://doi.org/10.1182/blood-2025-5806

Published: 2025

Journal Articles

Ultra-deep whole-genome sequencing of cell-free DNA recovers most bone marrow-derived mutations in newly diagnosed multiple myeloma

Dor Abelman, David Scott, Jenna Eagles, Stephanie Pedersen, Aimée Wong, Saumil Shah, Cecilia Bonolo De Campos, Darrel White, Irwindeep Sandhu, Kevin Song, Alli Murugesan, Anthony Reiman, Suzanne Trudel, Trevor Pugh

Blood (2025) 146 (Supplement 1): 495.

https://doi.org/10.1182/blood-2025-495

Published: 2025

Journal Articles

Evaluating targeted long-read sequencing as a diagnostic tool for burkitt lymphoma

Giuliano Banco, Kostiantyn Dreval, Laura Hilton, David Scott, Michael J. Trimble, Amy H. Y. Lee, Krysta Coyle, Ryan Morin

Blood (2025) 146 (Supplement 1): 3547.

https://doi.org/10.1182/blood-2025-3547

Published: 2025

Journal Articles

Long-term outcomes of patients with hairy cell leukemia treated with first-line cladribine in British Columbia

Jonathan Isenberg, Kerry Savage, David Scott, Laurie Sehn, Christopher Venner, Diego Villa, Alina Gerrie

Blood (2025) 146 (Supplement 1): 1805.

https://doi.org/10.1182/blood-2025-1805

Published: 2025

Journal Articles

Real world population-based outcome analysis of small lymphocytic lymphoma (SLL) in British Columbia (BC)

Solomon Abate, Steven Huang, Elysha Vanderveer, Diego Villa, Christopher Venner, David Scott, Kerry Savage, Laurie Sehn, Cynthia Toze, Alina Gerrie

Blood (2025) 146 (Supplement 1): 2748.

https://doi.org/10.1182/blood-2025-2748

Published: 2025

Journal Articles

Spen loss drives extra-follicular diffuse large B cell lymphoma with female-specific lethality and TLR pathway therapeutic vulnerabilities

Blood (2025) 146 (Supplement 1): 140.

https://doi.org/10.1182/blood-2025-140

Published: 2025

Journal Articles

Multimodal single-cell and spatial analyses reveal a distinct immune ecosystem in pediatric classic Hodgkin lymphoma

Shinichiro Oshima, Yifan Yin, Nawar Dakhallah, Rose Chami, Bo Ngan, Angela Punnett, Hang Yin, Isabella Kong, Shinya Rai, Adele Telenius, Robert Kridel, Federico Gaiti, David Scott, Kara Kelly, Debra Friedman, Sharon Castellino, Lisa Roth, Christian Steidl, Tomohiro Aoki

Blood (2025) 146 (Supplement 1): 3552.

https://doi.org/10.1182/blood-2025-3552

Published: 2025

Journal Articles

Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL

Blood (2024) 144 (10): 1083–1092.

https://doi.org/10.1182/blood.2024023962

Published: 2024

Includes: Supplemental data

Journal Articles

MALT1 Degradation with a Proteolysis-Targeting Chimera for the Treatment of Activated B-Cell Type Diffuse Large B-Cell Lymphoma

Madhav R Seshadri, Lorena Fontan, Prasanna Sreevatsan, David Scott, John Hatcher, Guangyan Du, Min Xia, Ilkay Us, Nathanael Gray, Ari Melnick

Blood (2021) 138 (Supplement 1): 269.

https://doi.org/10.1182/blood-2021-153855

Published: 2021

Journal Articles

Chemically Induced Degradation of MALT1 to Treat B-Cell Lymphomas

Lorena Fontan, PhD, John Hatcher, PhD, David Scott, Qi Qiao, Ilkay Us, Guangyan Du, Matthew Durant, Jimmy Wilson, Hao Wu, PhD, Nathanael Gray, Ari Melnick, MD

Blood (2019) 134 (Supplement_1): 2073.

https://doi.org/10.1182/blood-2019-130666

Published: 2019

Journal Articles

Characterization of Germline Variants in Multiple Myeloma

Fernanda Martins Rodrigues, MSc, Qingsong Gao, PhD, Kuan-lin Huang, PhD, Adam David Scott, PhD BA, MS, Steven M. Foltz, MS, Justin King, Mark A. Fiala, BS, Daniel R. Kohnen, MBA, John F. DiPersio, MD PhD, Ravi Vij, MBBS, Li Ding, PhD

Blood (2018) 132 (Supplement 1): 4499.

https://doi.org/10.1182/blood-2018-99-118673

Published: 2018

Journal Articles

Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 As a Therapeutic Target for Restoring MHC Expression in Diffuse Large B-Cell Lymphoma

Blood (2018) 132 (Supplement 1): 1560.

https://doi.org/10.1182/blood-2018-99-112010

Published: 2018

Journal Articles

Uncovering Clonal and Subclonal Druggable Targets in Multiple Myeloma Using Omic Data

Adam David Scott, PhD, Venkata D Yellapantula, PhD, Christopher J Yoon, BS, Michael Wendl, PhD, Michael H. Tomasson, MD, Mark A Fiala, BS, CCRP, John F. DiPersio, MD, PhD, Ravi Vij, MD, Li Ding, PhD

Blood (2016) 128 (22): 2084.

https://doi.org/10.1182/blood.V128.22.2084.2084

Published: 2016

Journal Articles

Analytical Validity of Deep Sequencing to Characterize Tissue-Infiltrating Lymphocytes

David Scott Johnson, PhD, Andrea Löhr, PhD, Walter Mathias Howell, PhD, Andro Hsu, PhD, Robert S. Negrin, MD, Everett H. Meyer, MD, PhD

Blood (2012) 120 (21): 3286.

https://doi.org/10.1182/blood.V120.21.3286.3286

Published: 2012

Journal Articles

The Expansion of Gastrointestinal-associated αβ T Cell Clones in Peripheral Blood Over Time Is a Disease Feature of Severe Acute Graft-Versus-Host Disease

Everett H. Meyer, MD, PhD, Joanna Liliental, PhD, Mareike Florek, MD, Andrea Löhr, PhD, Andro Hsu, PhD, David Scott Johnson, PhD, David B Miklos, MD, PhD, James L. Zehnder, Robert S. Negrin, MD

Blood (2012) 120 (21): 228.

https://doi.org/10.1182/blood.V120.21.228.228

Published: 2012

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Tumor intrinsic mechanisms leading to cevostamab resistance in multiple myeloma

Incidence and characteristics of infections in patients with multiple myeloma treated with BCMA bispecific antibodies in British Columbia

Ultra-deep whole-genome sequencing of cell-free DNA recovers most bone marrow-derived mutations in newly diagnosed multiple myeloma

Evaluating targeted long-read sequencing as a diagnostic tool for burkitt lymphoma

Long-term outcomes of patients with hairy cell leukemia treated with first-line cladribine in British Columbia

Real world population-based outcome analysis of small lymphocytic lymphoma (SLL) in British Columbia (BC)

Spen loss drives extra-follicular diffuse large B cell lymphoma with female-specific lethality and TLR pathway therapeutic vulnerabilities

Multimodal single-cell and spatial analyses reveal a distinct immune ecosystem in pediatric classic Hodgkin lymphoma

Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL

MALT1 Degradation with a Proteolysis-Targeting Chimera for the Treatment of Activated B-Cell Type Diffuse Large B-Cell Lymphoma

Chemically Induced Degradation of MALT1 to Treat B-Cell Lymphomas

Characterization of Germline Variants in Multiple Myeloma

Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 As a Therapeutic Target for Restoring MHC Expression in Diffuse Large B-Cell Lymphoma

Uncovering Clonal and Subclonal Druggable Targets in Multiple Myeloma Using Omic Data

Analytical Validity of Deep Sequencing to Characterize Tissue-Infiltrating Lymphocytes

The Expansion of Gastrointestinal-associated αβ T Cell Clones in Peripheral Blood Over Time Is a Disease Feature of Severe Acute Graft-Versus-Host Disease

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only